Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas.

Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N, Jain A, Edil BH, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL.

Ann Surg. 2010 Mar;251(3):470-6. doi: 10.1097/SLA.0b013e3181cf8a19.

2.

Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis.

Basturk O, Khayyata S, Klimstra DS, Hruban RH, Zamboni G, Coban I, Adsay NV.

Am J Surg Pathol. 2010 Mar;34(3):364-70. doi: 10.1097/PAS.0b013e3181cf8bb6.

3.

Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program.

Albores-Saavedra J, Schwartz AM, Batich K, Henson DE.

J Surg Oncol. 2009 Dec 1;100(7):598-605. doi: 10.1002/jso.21374.

PMID:
19697352
4.

Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.

Schönleben F, Qiu W, Allendorf JD, Chabot JA, Remotti HE, Su GH.

J Gastrointest Surg. 2009 Aug;13(8):1510-6. doi: 10.1007/s11605-009-0917-4. Epub 2009 May 14.

5.

Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Yamaguchi H, Shimizu M, Ban S, Koyama I, Hatori T, Fujita I, Yamamoto M, Kawamura S, Kobayashi M, Ishida K, Morikawa T, Motoi F, Unno M, Kanno A, Satoh K, Shimosegawa T, Orikasa H, Watanabe T, Nishimura K, Ebihara Y, Koike N, Furukawa T.

Am J Surg Pathol. 2009 Aug;33(8):1164-72. doi: 10.1097/PAS.0b013e3181a162e5.

PMID:
19440145
6.

Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications.

Basturk O, Coban I, Adsay NV.

Arch Pathol Lab Med. 2009 Mar;133(3):423-38. doi: 10.1043/1543-2165-133.3.423. Review.

PMID:
19260748
7.

Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior.

Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M.

Proteomics. 2008 Aug;8(16):3329-41. doi: 10.1002/pmic.200800040. Review.

PMID:
18651706
8.

Large periampullary villous tumor of the duodenum.

Cavallini M, Cavaniglia D, Felicioni F, Vitale V, Pilozzi E, Ziparo V.

J Hepatobiliary Pancreat Surg. 2007;14(5):526-8. Epub 2007 Sep 28.

PMID:
17909726
9.

Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases.

Rouzbahman M, Serra S, Adsay NV, Bejarano PA, Nakanuma Y, Chetty R.

Pathology. 2007 Aug;39(4):413-8.

PMID:
17676483
10.

Mucin expression profile in pancreatic cancer and the precursor lesions.

Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, Yonezawa S.

J Hepatobiliary Pancreat Surg. 2007;14(3):243-54. Epub 2007 May 29. Review.

PMID:
17520199
11.

Biliary cystic intraductal papillary mucinous tumor and cystadenoma/cystadenocarcinoma: differentiation by CT.

Lim JH, Jang KT, Rhim H, Kim YS, Lee KT, Choi SH.

Abdom Imaging. 2007 Sep-Oct;32(5):644-51.

PMID:
17437076
12.

Intraductal papillary mucinous tumors of both biliary and pancreatic ducts.

Zalinski S, Paradis V, Valla D, Belghiti J.

J Hepatol. 2007 May;46(5):978-9. Epub 2007 Mar 2. No abstract available.

PMID:
17391800
13.

Primary duodenal neoplasms: a retrospective clinico-pathological analysis.

Bal A, Joshi K, Vaiphei K, Wig JD.

World J Gastroenterol. 2007 Feb 21;13(7):1108-11.

14.

Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas.

Zen Y, Fujii T, Itatsu K, Nakamura K, Minato H, Kasashima S, Kurumaya H, Katayanagi K, Kawashima A, Masuda S, Niwa H, Mitsui T, Asada Y, Miura S, Ohta T, Nakanuma Y.

Hepatology. 2006 Nov;44(5):1333-43.

PMID:
17058219
15.

Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.

Zen Y, Fujii T, Itatsu K, Nakamura K, Konishi F, Masuda S, Mitsui T, Asada Y, Miura S, Miyayama S, Uehara T, Katsuyama T, Ohta T, Minato H, Nakanuma Y.

Mod Pathol. 2006 Sep;19(9):1243-54. Epub 2006 Jun 2.

16.

Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm?

Klöppel G, Kosmahl M.

J Hepatol. 2006 Feb;44(2):249-50. Epub 2005 Dec 6. No abstract available.

PMID:
16360969
18.

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology.

Pancreatology. 2006;6(1-2):17-32. Review.

19.

Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS, Longnecker DS, Lüttges J, Offerhaus GJ, Shimizu M, Sunamura M, Suriawinata A, Takaori K, Yonezawa S.

Virchows Arch. 2005 Nov;447(5):794-9. Epub 2005 Aug 9.

PMID:
16088402
20.

Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation.

Tajiri T, Tate G, Inagaki T, Kunimura T, Inoue K, Mitsuya T, Yoshiba M, Morohoshi T.

Pancreas. 2005 Mar;30(2):115-21.

PMID:
15714133

Supplemental Content

Support Center